Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

NRSNW NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM)

Watchlist
0.2750.0000.00%
Close  02/03 16:00 ET
High
0.000
Open
0.275
Turnover
7.00
Low
0.000
Pre Close
0.275
Volume
31.00
Market Cap
0
P/E(TTM)
0.00
52wk High
1.950
Shares
0
P/E(Static)
0.00
52wk Low
0.160
Float Cap
0
Bid/Ask %
33.33%
Historical High
1.950
Shs Float
0
Volume Ratio
0.01
Historical Low
0.160
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.225
Lot Size
1
Float Cap
0
Bid/Ask %
33.33%
Historical High
1.950
Shs Float
0
Volume Ratio
0.01
Historical Low
0.160
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.225
Lot Size
1
Price Forecast

News

Comment

No Data

Company Overview More
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer’s and Parkinson’s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
CEO: Mr. Alon Ben-Noon
Market: NASDAQ
Listing Date: 12/09/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist